1. The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib
   Pawel Robak et al, 2021, Cancers CrossRef
2. Discovery and Optimization of Highly Selective Inhibitors of CDK5
   Matthew H. Daniels et al, 2022, Journal of Medicinal Chemistry CrossRef
3. The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
   Paweł Robak et al, 2020, Cancers CrossRef